Dornase alpha and survival of patients with cystic fibrosis.
作者信息
McIntyre A M
机构信息
Roche Products Ltd, Welwyn Garden City, Hertfordshire.
出版信息
Hosp Med. 1999 Oct;60(10):736-9. doi: 10.12968/hosp.1999.60.10.1218.
Abstract
Dornase alpha can offer substantial clinical benefits to cystic fibrosis patients, but its long-term impact is as yet unknown. This article attempts to model the impact of continuous dornase alpha use on patient survival and its cost implications for the health-care provider.
摘要
Zotero 插件